Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Infectious Disease Reports
Published in: Current Infectious Disease Reports 5/2012

01-10-2012 | Skin, Soft Tissue, Bone, and Joint Infections (N Safdar, Section Editor)

Prosthetic Joint Infections

Authors: Saima Aslam, Rabih O. Darouiche

Published in: Current Infectious Disease Reports | Issue 5/2012

Login to get access

Abstract

Prosthetic joint infections represent a major therapeutic challenge for both healthcare providers and patients. This article reviews the predisposing factors, pathogenesis, microbiology, diagnosis, treatment, and prophylaxis of prosthetic joint infection. The most optimal management strategy should be identified on the basis of a number of considerations, including type and duration of infection, antimicrobial susceptibility of the infecting pathogen, condition of infected tissues and bone stock, patient wishes, and functional status.
Literature
1.
Lentino JR. Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists. Clin Infect Dis. 2003;36(9):1157–61.PubMedCrossRef
2.
Blom AW, Brown J, Taylor AH, et al. Infection after total knee arthroplasty. J Bone Joint Surg Br. 2004;86(5):688–91.PubMedCrossRef
3.
Blom AW, Taylor AH, Pattison G, et al. Infection after total hip arthroplasty. The Avon experience. J Bone Joint Surg Br. 2003;85(7):956–9.PubMedCrossRef
4.
Berbari EF, Hanssen AD, Duffy MC, et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis. 1998;27(5):1247–54.PubMedCrossRef
5.
Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am. 2005;87(8):1746–51.PubMedCrossRef
6.
Poss R, Thornhill TS, Ewald FC, et al. Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clin Orthop Relat Res. 1984;(182):117-26.
7.
Kaandorp CJ, Dinant HJ, van de Laar MA, et al. Incidence and sources of native and prosthetic joint infection: a community based prospective survey. Ann Rheum Dis. 1997;56(8):470–5.PubMedCrossRef
8.
Wilson MG, Kelley K, Thornhill TS. Infection as a complication of total knee-replacement arthroplasty. Risk factors and treatment in sixty-seven cases. J Bone Joint Surg Am. 1990;72(6):878–83.PubMed
9.
Bongartz T, Halligan CS, Osmon DR, et al. Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum. 2008;59(12):1713–20.PubMedCrossRef
10.
Choong PF, Dowsey MM, Carr D, et al. Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampinbased regimen. Acta Orthop. 2007;78(6):755–65.PubMedCrossRef
11.
Aslam S, Reitman C, Darouiche RO. Risk factors for subsequent diagnosis of prosthetic joint infection. Infect Control Hosp Epidemiol. 31(3):298-301.
12.
Jamsen E, Huhtala H, Puolakka T, Moilanen T. Risk factors for infection after knee arthroplasty. A register-based analysis of 43,149 cases. J Bone Joint Surg Am. 2009;91(1):38–47.PubMedCrossRef
13.
Ong KL, Kurtz SM, Lau E, et al. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty. 2009;24(6 Suppl):105–9.PubMedCrossRef
14.
Font-Vizcarra L, Tornero E, Bori G, et al. Relationship between intraoperative cultures during hip arthroplasty, obesity, and the risk of early prosthetic joint infection: a prospective study of 428 patients. International J Artif Organs. 2011;34(9):870–5. Epub 2011/11/19.CrossRef
15.
Aslam S. Effect of antibacterials on biofilms. Am J Infect Control. 2008;36(10):S175.e9–S175.e11. Epub 2008/12/17.CrossRef
16.
•• Zimmerli W, Moser C. Pathogenesis and treatment concepts of orthopaedic biofilm infections. FEMS Immunol Med Microbiol. 2012;65(2):158–68. Epub 2012/02/09. This article discusses the pathogenesis of PJI in detail, with emphasis on biofilm and its interaction with antimicrobials.PubMedCrossRef
17.
Trampuz A, Piper KE, Jacobson MJ, et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med. 2007;357(7):654–63. Epub 2007/08/19.PubMedCrossRef
18.
Peel TN, Cheng AC, Buising KL, Choong PF. Microbiological aetiology, epidemiology, and clinical profile of prosthetic joint infections: are current antibiotic prophylaxis guidelines effective? Antimicrob Agents Chemother. 2012;56(5):2386–91. Epub 2012/02/09.PubMedCrossRef
19.
Leung F, Richards CJ, Garbuz DS, et al. Two-stage total hip arthroplasty: how often does it control methicillin-resistant infection? Clin Orthop Relat Res. 2011;469(4):1009–15. Epub 2010/12/17.PubMedCrossRef
20.
•• Del Pozo JL, Patel R. Clinical practice. Infection associated with prosthetic joints. New England J Med. 2009;361(8):787–94. Epub 2009/08/21. This review article discusses the clinical management of PJI.CrossRef
21.
Malekzadeh D, Osmon DR, Lahr BD, et al. Prior use of antimicrobial therapy is a risk factor for culture-negative prosthetic joint infection. Clin Orthop Relat Res. 2010;468(8):2039–45. Epub 2010/04/20.PubMedCrossRef
22.
Atkins BL, Athanasou N, Deeks JJ, et al. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS collaborative study group. J Clin Microbiol. 1998;36(10):2932–9. Epub 1998/09/17.PubMed
23.
Hughes JG, Vetter EA, Patel R, et al. Culture with BACTEC Peds Plus/F bottle compared with conventional methods for detection of bacteria in synovial fluid. J Clin Microbiol. 2001;39(12):4468–71. Epub 2001/11/29.PubMedCrossRef
24.
Sorli L, Puig L, Torres-Claramunt R, et al. The relationship between microbiology results in the second of a two-stage exchange procedure using cement spacers and the outcome after revision total joint replacement for infection: the use of sonication to aid bacteriological analysis. J Bone Joint Surg British Vol. 2012;94(2):249–53. Epub 2012/02/11.CrossRef
25.
Piper KE, Fernandez-Sampedro M, Steckelberg KE, et al. C-reactive protein, erythrocyte sedimentation rate and orthopedic implant infection. PLoS One. 2010;5(2):e9358. Epub 2010/02/25.PubMedCrossRef
26.
Kusuma SK, Ward J, Jacofsky M, et al. What is the role of serological testing between stages of two-stage reconstruction of the infected prosthetic knee? Clin Orthop Relat Res. 2011;469(4):1002–8. Epub 2010/10/14.PubMedCrossRef
27.
Bjerkan G, Witso E, Nor A, et al. A comprehensive microbiological evaluation of fifty-four patients undergoing revision surgery due to prosthetic joint loosening. J Med Microbiol. 2012;61(Pt 4):572–81. Epub 2011/12/03.PubMedCrossRef
28.
Esteban J, Alonso-Rodriguez N, Del-Prado G, et al. PCR-hybridization after sonication improves diagnosis of implant-related infection. Acta Orthop. 2012;83(3):299–304. Epub 2012/05/24.PubMedCrossRef
29.
Brause BD. Infections with prostheses in bones and joints. In: Gerald M. Mandell JEB, Raphael Dolin, editors. Mandell, Douglas and Bennet’s principles and practice of infectious diseases. sixth ed2005. p. 1332-47.
30.
Karchmer AW. In: Gorbach SLBJ, Blacklow NR, editors. Infections in a Prosthetic Device. Philadelphia: WB Saunders; 1998. p. 1666–78.
31.
El-Ghannam A, Jahed K, Govindaswami M. Resorbable bioactive ceramic for treatment of bone infection. J Biomed Mater Res Part A. 2010;94(1):308–16. Epub 2010/02/27.CrossRef
32.
Kazemzadeh-Narbat M, Kindrachuk J, Duan K, et al. Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infections. Biomaterials. 2010;31(36):9519–26. Epub 2010/10/26.PubMedCrossRef
33.
Lieberman JR, Callaway GH, Salvati EA, et al. Treatment of the infected total hip arthroplasty with a two-stage reimplantation protocol. Clin Orthop Relat Res. 1994;301:205–12.PubMed
34.
McDonald DJ, Fitzgerald Jr RH, Ilstrup DM. Two-stage reconstruction of a total hip arthroplasty because of infection. J Bone Joint Surg Am. 1989;71(6):828–34.PubMed
35.
Hanssen AD, Rand JA. Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. J Bone Joint Surg Am. 1998;80-A(6):910–22.
36.
Colyer RA, Capello WN. Surgical treatment of the infected hip implant. Two-stage reimplantation with a one-month interval. Clin Orthop Relat Res. 1994;298:75–9.PubMed
37.
Sanchez-Sotelo J, Berry DJ, Hanssen AD, Cabanela ME. Midterm to long-term followup of staged reimplantation for infected hip arthroplasty. Clin Orthop Relat Res. 2009;467(1):219–24.PubMedCrossRef
38.
Masri BA, Panagiotopoulos KP, Greidanus NV, et al. Cementless two-stage exchange arthroplasty for infection after total hip arthroplasty. J Arthroplast. 2007;22(1):72–8.CrossRef
39.
Bejon P, Berendt A, Atkins BL, et al. Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology. J Antimicrob Chemother.65(3):569-75.
40.
Hanssen AD, Trousdale RT, Osmon DR. Patient outcome with reinfection following reimplantation for the infected total knee arthroplasty. Clin Orthop Relat Res. 1995;321:55–67.PubMed
41.
Haleem AA, Berry DJ, Hanssen AD. Mid-term to long-term followup of two-stage reimplantation for infected total knee arthroplasty. Clin Orthop Relat Res. 2004;428:35–9.PubMedCrossRef
42.
Gooding CR, Masri BA, Duncan CP, et al. Durable infection control and function with the PROSTALAC spacer in two-stage revision for infected knee arthroplasty. Clin Orthop Relat Res. 2011;469(4):985–93. Epub 2010/09/30.PubMedCrossRef
43.
Hsieh PH, Huang KC, Lee PC, Lee MS. Two-stage revision of infected hip arthroplasty using an antibiotic-loaded spacer: retrospective comparison between short-term and prolonged antibiotic therapy. J Antimicrob Chemother. 2009;64(2):392–7.PubMedCrossRef
44.
Whittaker JP, Warren RE, Jones RS, Gregson PA. Is prolonged systemic antibiotic treatment essential in two-stage revision hip replacement for chronic Gram-positive infection? J Bone Joint Surg British Vol. 2009;91(1):44–51. Epub 2008/12/19.CrossRef
45.
Della Valle CJ, Bogner E, Desai P, et al. Analysis of frozen sections of intraoperative specimens obtained at the time of reoperation after hip or knee resection arthroplasty for the treatment of infection. J Bone Joint Surg Am. 1999;81(5):684–9.PubMed
46.
Mont MA, Waldman BJ, Hungerford DS. Evaluation of preoperative cultures before second-stage reimplantation of a total knee prosthesis complicated by infection. A comparison-group study. J Bone Joint Surg Am. 2000;82-A(11):1552–7.PubMed
47.
Lonner JH, Siliski JM, Della Valle C, et al. Role of knee aspiration after resection of the infected total knee arthroplasty. Am J Orthop. 2001;30(4):305–9.PubMed
48.
Klouche S, Leonard P, Zeller V, et al. Infected total hip arthroplasty revision: one- or two-stage procedure? Orthop & Traumatol, Surg & Res: OTSR. 2012;98(2):144–50. Epub 2012/03/01.CrossRef
49.
Koyonos L, Zmistowski B, Della Valle CJ, Parvizi J. Infection control rate of irrigation and debridement for periprosthetic joint infection. Clin Orthop Relat Res. 2011;469(11):3043–8. Epub 2011/05/10.PubMedCrossRef
50.
Gardner J, Gioe TJ, Tatman P. Can this prosthesis be saved?: implant salvage attempts in infected primary TKA. Clin Orthop Relat Res. 2011;469(4):970–6. Epub 2010/06/15.PubMedCrossRef
51.
Choi HR, von Knoch F, Zurakowski D, et al. Can implant retention be recommended for treatment of infected TKA? Clin Orthop Relat Res. 2011;469(4):961–9. Epub 2010/11/17.PubMedCrossRef
52.
Brandt CM, Sistrunk WW, Duffy MC, et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis. 1997;24(5):914–9.PubMedCrossRef
53.
Meehan AM, Osmon DR, Duffy MC, et al. Outcome of penicillin-susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis. Clin Infect Dis. 2003;36(7):845–9.PubMedCrossRef
54.
Crockarell JR, Hanssen AD, Osmon DR, Morrey BF. Treatment of infection with debridement and retention of the components following hip arthroplasty. J Bone Joint Surg Am. 1998;80(9):1306–13.PubMed
55.
Schoifet SD, Morrey BF. Treatment of infection after total knee arthroplasty by debridement with retention of the components. J Bone Joint Surg Am. 1990;72(9):1383–90.PubMed
56.
Tattevin P, Cremieux AC, Pottier P, et al. Prosthetic joint infection: when can prosthesis salvage be considered? Clin Infect Dis. 1999;29(2):292–5.PubMedCrossRef
57.
Teeny SM, Dorr L, Murata G, Conaty P. Treatment of infected total knee arthroplasty. Irrigation and debridement versus two-stage reimplantation. J Arthroplast. 1990;5(1):35–9. Epub 1990/03/01.CrossRef
58.
Mont MA, Waldman B, Banerjee C, et al. Multiple irrigation, debridement, and retention of components in infected total knee arthroplasty. J Arthroplast. 1997;12(4):426–33. Epub 1997/06/01.CrossRef
59.
Byren I, Bejon P, Atkins BL, et al. One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother. 2009;63(6):1264–71. Epub 2009/04/02.PubMedCrossRef
60.
Salgado CD, Dash S, Cantey JR, Marculescu CE. Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin Orthop Relat Res. 2007;461:48–53. Epub 2007/05/31.PubMed
61.
Zimmerli W, Widmer AF, Blatter M, et al. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA: J Am Med Assoc. 1998;279(19):1537–41. Epub 1998/05/30.CrossRef
62.
Pavoni GL, Giannella M, Falcone M, et al. Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience. Clin Microbiol Infect: Off Publ Eur Soc Clin Microbiol Infect Dis. 2004;10(9):831–7. Epub 2004/09/10.
63.
Rao N, Crossett LS, Sinha RK, Le Frock JL. Long-term suppression of infection in total joint arthroplasty. Clinical orthopaedics and related research. 2003(414):55-60. Epub 2003/09/11.
64.
Widmer AF, Gaechter A, Ochsner PE, Zimmerli W. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clini Infect Dis: Off Publ Infect Dis Soc Am. 1992;14(6):1251–3. Epub 1992/06/01.
65.
66.
Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2004;38(12):1706–15. Epub 2004/07/01.
67.
68.
Little JW, Jacobson JJ, Lockhart PB. The dental treatment of patients with joint replacements: a position paper from the American Academy of Oral Medicine. J Am Dent Assoc. 2010;141(6):667–71. Epub 2010/06/03.PubMed
69.
•• Berbari EF, Osmon DR, Carr A, et al. Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2010;50(1):8–16. Epub 2009/12/03. This study showed that dental procedures are not associated with subsequent diagnosis of PJI.
Metadata
Title
Prosthetic Joint Infections
Authors
Saima Aslam
Rabih O. Darouiche
Publication date
01-10-2012
Publisher
Current Science Inc.
Published in
Current Infectious Disease Reports / Issue 5/2012
Print ISSN: 1523-3847
Electronic ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-012-0284-2

Other articles of this Issue 5/2012

Current Infectious Disease Reports 5/2012 Go to the issue

Sepsis (J Russell, Section Editor)

Toll-Like Receptors and Opportunities for New Sepsis Therapeutics

Sepsis (J Russell, Section Editor)

Management of Acute Renal Dysfunction in Sepsis

Sepsis (J Russell, Section Editor)

Immunoglobulins in Adult Sepsis and Septic Shock

Sepsis (J Russell, Section Editor)

Immune Aspects of Sepsis and Hope for New Therapeutics

Sepsis (J Russell, Section Editor)

HMG-CoA Reductase Inhibitors for Prevention and Treatment of Severe Sepsis

Sepsis (J Russell, Section Editor)

Pediatric Sepsis: Preparing for the Future Against a Global Scourge
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits